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Abstract 
Background: Depression and alcohol misuse are among the most prevalent diagnoses in 
suicide fatalities. The risk posed by these disorders is exacerbated when they co-occur. 
Limited research has evaluated the effectiveness of common depression and alcohol 
treatments for the reduction of suicide vulnerability in individuals experiencing comorbidity.  
Methods: Participants with depressive symptoms and hazardous alcohol use were selected 
from two randomised controlled trials. They had received either a brief (1 session) 
intervention, or depression-focused cognitive behaviour therapy (CBT), alcohol-focused CBT, 
therapist-delivered integrated CBT, computer-delivered integrated CBT or Person-Centred 
Therapy (PCT) over a 10-week period. Suicidal ideation, hopelessness, depression severity 
and alcohol consumption were assessed at baseline and 12-month follow-up. 
Results: 303 participants were assessed at baseline and 12 months. Both suicidal ideation 
and hopelessness were associated with higher severity of depressive symptoms, but not 
with alcohol consumption. Suicidal ideation did not improve significantly at follow-up, with 
no differences between treatment conditions. Improvements in hopelessness differed 
between treatment conditions; hopelessness improved more in the CBT conditions compared 
to PCT and in single-focused CBT compared to integrated CBT.  
Limitations: Low retention rates may have impacted on the reliability of our findings. 
Combining data from two studies may have resulted in heterogeneity of samples between 
conditions. 
Conclusions: CBT appears to be associated with reductions in hopelessness in people with 
co-occurring depression and alcohol misuse, even when it is not the focus of treatment. Less 
consistent results were observed for suicidal ideation. Establishing specific procedures or 
therapeutic content for clinicians to monitor these outcomes may result in better 
management of individuals with higher vulnerability for suicide.  
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Introduction 
Suicide is an issue of major concern among clinical populations, with approximately 90% of 
suicide victims experiencing a psychiatric condition at their time of death (Mann et al., 
2005). Particular attention has been paid to the impact of depression and alcohol abuse on 
suicidality, both of which pose an independent suicide risk (You et al., 2011). These 
conditions frequently co-occur (Teesson et al., 2009), particularly in clinical settings (Davis 
et al., 2006; Lubman et al., 2007), further exacerbating the vulnerability for suicidal 
thoughts and behaviours (Bartels et al., 2002; Cornelius et al., 1995; Sher et al., 2005, 
2008; Schneider, 2009).  
In clinical populations, hopelessness and suicidal ideation have been ranked as the 
first and second most important suicide risk factors respectively, and are perceived to be 
reliable indicators of an individual’s future potential for suicide (Truant et al., 1991). In 
clinical settings, elevated hopelessness has been reliably shown to be present in over 90% 
of individuals who eventually die by suicide, with these findings replicated in both inpatients 
and outpatients (Beck et al., 1985; 1990). Similarly, significant levels of suicidal ideation are 
observed in 80% of psychiatric outpatients who take their own life (Beck et al., 1999). Both 
symptoms are reported frequently in individuals with a diagnosis of depression, and may be 
more severe among individuals with comorbid alcohol misuse (Sher et al., 2005). However, 
the specific relationship between suicide vulnerability (i.e. markers of suicidality such as 
suicidal ideation and hopelessness) and comorbidity remains unclear. While suicidal ideation 
is related to the severity of depression (Gensichen et al., 2010), alcohol use disorders in 
themselves do not predict thoughts of suicide (Kelly et al., 2001). This is despite alcohol 
misuse being associated with significantly increased severity of depressive symptoms, and 
alcohol misuse and depression likely exerting a synergistic impact on suicide risk, with co-
occurrence of these disorders contributing to greater risk than either occurring in isolation 
(Fergusson et al., 2009). For example, Effinger and Stewart (2012) have recently shown 
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that, among adolescents in the USA with either a depressive or substance use disorder, the 
presence of even sub-threshold symptoms of the other disorder significantly increases risk of 
suicide. Other research shows no direct correlation between hopelessness and clinical 
indications of either depressive symptoms or alcohol misuse (Whisman et al., 1995). The 
implications of this in a clinical setting are considerable: while individuals with depression 
and alcohol misuse are a high-risk group for suicidal behaviours, these findings suggest that 
targeting these primary conditions alone may be insufficient to reduce this vulnerability. 
Cognitive behaviour therapy (CBT) is among the most common and effective 
treatments for both depression and alcohol use problems, and can be used to address these 
conditions either independently or in an integrated format (Kay-Lambkin et al., 2011; Baker 
et al., 2010; Kay-Lambkin et al., 2009). Recent evidence has also been found to support the 
use of computer-delivered CBT, which is equally effective in reducing depressive symptoms 
and substance use, while increasing the accessibility of treatment (Kay-Lambkin et al., 
2011). It has been suggested that cognitive therapy, which focuses on reducing 
dysfunctional attitudes in depression, may be uniquely appropriate for addressing both 
hopelessness and suicidal ideation (Rush et al., 1982; Raj et al., 2001). While CBT generally 
targets a client’s “primary” diagnosis, integrated treatment for comorbid depression and 
alcohol misuse is emerging as an important approach in the context of comorbid disorders. 
Evidence suggests that combining treatments may lead to a greater decrease in symptoms 
of both depression and alcohol use than observed through single-focused treatments for 
either condition alone (Baker et al., 2010). It has also been suggested that for people with 
comorbid conditions, integrated treatments may be necessary to reduce suicide vulnerability 
(Lecrubier et al., 2001). However, to our knowledge there is no research exploring 
integrated treatments, either therapist- or computer-delivered, that tests this suggestion, 
and includes suicide vulnerability as an outcome.  
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While CBT may be an ideal approach to decrease suicide vulnerability among 
individuals with depression and alcohol misuse comorbidity, its effectiveness has rarely been 
tested in this context. Although some research has found CBT to be effective at targeting 
both suicidal ideation and hopelessness in clinical populations (Rush et al., 1982; Raj et al., 
2001), conflicting results indicate cognitive therapy is no more effective than usual care in 
the immediate or long-term, with only marginal effects witnessed for hopelessness at 6-
months (Brown et al., 2005). However, existing studies have either been inadequately 
powered, or only have explored interventions concerned with short-term treatment 
outcomes (e.g. Rush et al., 1982; Stewart et al., 2009), with longer-term effects not 
reported. The validation of existing findings using a larger sample and a longer-term 
longitudinal design may help clarify the effectiveness of CBT in addressing suicide 
vulnerability. Additionally, previous studies have primarily explored cognitive therapy that 
specifically focuses on the reduction of suicidal thoughts and behaviours. While this is 
valuable knowledge, it is also important to explore the effects of therapies that do not 
directly target suicidality. Standard practice in therapy is to treat the primary condition with 
which the client presents, and while suicide risk may be noted, it is not necessarily 
highlighted as a focus of concern (Oquendo et al., 2008). It is therefore important to 
evaluate the typical approach of treating the conditions of depression and alcohol abuse to 
determine the independent effects of this non-targeted treatment on suicide vulnerability. 
  The primary aims of the present analysis were: 1) to explore whether CBT, targeting 
depression and alcohol misuse, is associated with clinically significant reductions in  
indicators of suicide vulnerability (suicidal ideation and hopelessness) over a 12-month 
period in a large sample with sufficient power to detect expected clinical effects; 2) to 
investigate whether the method of treatment delivery (i.e. single-focused compared to 
integrated treatment, therapist-delivered versus computer-delivered treatment) is associated 
with differential effects on the course of suicide vulnerability; and 3) to determine whether 
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changes in suicide vulnerability indicators occur in accordance with change in depression 
and/or alcohol use, or independently from these conditions. We hypothesised that CBT will 
effectively reduce suicide vulnerability when compared to a control treatment of supportive 
counselling, and that integrated treatment will lead to a greater reduction in suicide 
vulnerability in a sample with comorbid conditions. Based on previous research, we 
predicted no differences between therapist-delivered and computer-delivered treatments 
(Kay-Lambkin et al., 2011), or between brief and 10-session treatments (Baker et al., 2010). 
 
Methods 
Study context 
The authors have previously conducted two clinical trials (Baker et al., 2010; Kay-
Lambkin et al., 2011) comparing a variety of treatment types for the outcomes of 
depression and substance use in people with comorbidity (known as the DAISI and SHADE 
projects). These studies were the first large-scale clinical trials of CBT for comorbid 
depression and alcohol/other drug use problems.   
1) The Depression and Alcohol Integrated and Single-focused Interventions project 
(DAISI; recruitment phase: October 2005 to May 2007) was designed to compare 
single-focused (depression or alcohol) and integrated CBT for co-occurring 
depression and alcohol misuse. This study also incorporated a brief (1 session) 
intervention.  
2) The Self-Help for Alcohol and other drug use and Depression project (SHADE; 
recruitment phase: May 2004 to February 2006) compared therapist-delivered and 
computer-delivered integrated CBT with a control condition of Person-Centred 
Therapy (PCT) for the treatment of co-occurring depression and substance use. As 
participants may have been using more than one substance (i.e. alcohol and/or 
cannabis) at harmful levels, all participants were randomised in an identical way, and 
8 
 
treatment was tailored to the individual to include information about cannabis only, 
alcohol only, or cannabis and alcohol, as was relevant to the individual. To increase 
comparability with DAISI participants, only those who met criteria for alcohol misuse 
are included in the analysis for the current paper. 
While depression and substance use were the primary outcomes of these studies, a 
number of important domains were measured, including suicidal ideation and hopelessness, 
which have not been previously reported. These studies present an opportunity to explore 
the correlates of indicators of suicide vulnerability among this important comorbid 
population, and to examine the impact on suicide vulnerability, if any, of CBT-focused 
treatments for depression and alcohol use problems. The current paper reports findings 
from a combination of datasets for people who met study entry criteria for hazardous use of 
alcohol and at least moderate depressive symptomatology, with evidence of suicide 
vulnerability at the time of recruitment. 
 
Rationale for combining data sets 
Integrating data across independent studies has become increasingly common over 
the past decade, and has been associated with a range of methodological benefits (Stewart 
et al., 2012; Cooper & Patall, 2009; Stewart & Tierney, 2002). These include maximising the 
utility of previously collected data, the ability to increase statistical power, and reducing 
attrition effects. This may be particularly useful in clinical research, which tends to have 
smaller samples initially, as well as often experiencing higher attrition than general 
population studies. Ideal circumstances for pooling across data sets have been loosely 
identified as those in which the same measures have been collected in comparable 
circumstances (Bauer & Hussong, 2009; Hofer & Piccinin, 2009). Challenges posed to clinical 
research by this approach, such as differing participant groups or treatment types, have 
been addressed in previous research by imposing unified inclusion criteria across studies, or 
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controlling for potential sources of difference, before conducting pooled analyses (Baker et 
al., 2009). 
From the time of their conception, the DAISI and SHADE studies were streamlined to 
allow for such integration, with efforts made to maximise the comparability of these data 
sets. These studies were identical in terms of their inclusion criteria (with the exception that 
SHADE allowed for the hazardous use of cannabis in the absence of alcohol misuse), 
recruitment techniques and sampling methods, therapy content, follow-up time intervals, 
and variables assessed. For the present analysis, pooling the DAISI and SHADE data sets 
not only increases the sample size, but also expands the capacity to address our research 
question, by allowing comparisons between treatment types that would not be possible if 
analysing the data sets independently. 
 
Participants 
Participants were recruited as part of the DAISI (Baker et al., 2010) and SHADE 
(Kay-Lambkin et al., 2011) clinical trials. Inclusion criteria for these studies were: elevated 
depressive symptoms (a score of ≥17 on the Beck Depression Inventory II [BDI-II]) (Beck 
et al., 1996) and concurrent use of alcohol at higher than the recommended drinking levels 
in Australia at the time of the studies (two standard drinks per day for females and four for 
males; one standard drink equates to 10g ethanol). Participants were recruited through self-
referral or sources such as outpatient drug treatment clinics, general practices and non-
government support agencies.  
From the existing DAISI and SHADE studies, participants were selected for the 
present analyses based on level of suicide vulnerability at baseline assessment. Participants 
were included if they reported either moderate hopelessness (Beck Hopelessness Scale 
[BHS] score of ≥ 9) (Beck et al., 1974) or moderate suicidal ideation (BDI-II item 9 score of 
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≥ 2); or both mild hopelessness and mild suicidal ideation (BHS score ≥ 4 and BDI-II item 9 
score ≥1). 
 
Treatment types 
Across the DAISI and SHADE studies, all participants received one session of face-to-
face integrated treatment with a therapist, and were then randomised to one of six 
treatment conditions: no further intervention (DAISI), depression-focused CBT (DAISI), 
alcohol-focused CBT (DAISI), therapist-delivered integrated CBT (DAISI & SHADE), 
computer-delivered integrated CBT (SHADE), or Person-Centred Therapy (PCT) (SHADE). 
The allocation of DAISI and SHADE participants to each treatment condition is described in 
Figure 1. All conditions received individual (as opposed to group) therapy. Both SHADE and 
DAISI included an integrated treatment condition, while single-focused treatment was an 
option only in DAISI. Similarly, PCT and computer-delivered CBT were offered only in 
SHADE. Consequently, a smaller number of participants received these treatments. The 
content of each treatment type was as follows: 
 Single-focused CBT: Nine 1-hour sessions conducted face-to-face with a trained 
therapist with therapy strategies directed towards the primary condition of interest 
(depression-focused or alcohol-focused). 
 Therapist-integrated CBT: Nine 1-hour sessions conducted face-to-face with a trained 
therapist incorporating treatment strategies relating to both depression and alcohol 
misuse, making explicit links between conditions. 
 Computer-integrated CBT: Nine 1-hour sessions of CBT delivered by CD-ROM where 
the content of each session mirrored that of the therapist-integrated treatment. 
There was a brief check-in with a therapist at the completion of each session to 
monitor participants’ symptoms (including suicidality). 
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 PCT: Nine 1-hour sessions of supportive counselling with the content and direction of 
the sessions directed by the participant; this condition was included as a control for 
therapist contact. 
 
Insert Figure 1 near here 
 
All CBT conditions also received motivational interviewing integrated into their 
sessions throughout their treatment period. No treatment condition involved content 
specifically directed towards the reduction of suicide vulnerability or the management of 
hopelessness, however, a protocol was developed to address suicidal thoughts or plans if 
these became apparent during therapy. All treatments were manualised and are described 
more fully elsewhere (Kay-Lambkin et al., 2005 [DAISI]; Kay-Lambkin et al., 2002 
[SHADE]); they are also available upon request. 
 
Measures 
Depression and alcohol use 
Depressive symptoms were assessed by the BDI-II. Due to strong associations 
between the BDI-II and both suicidal ideation and hopelessness, item 2 (pessimism) and 
item 9 (suicidal thoughts or wishes) were excluded from the current analyses, as the 
inclusion of these items may have resulted in artificial associations between the BDI-II and 
our outcomes. This approach has been taken in previous research (Beck et al., 1993). A cut-
off score of ≥17 was imposed on the modified measure for inclusion in the present study. 
Participants completed the Opiate Treatment Index (OTI) (Darke et al., 1991) to assess their 
alcohol use in the month prior to assessment. These inventories were completed at baseline 
and 12-month follow-up. The Structured Clinical Interview for DSM-IV Disorders (SCID) 
(First et al., 2001) was completed at baseline to assess clinical diagnoses of Major 
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Depression and Alcohol Abuse/Dependence according to Diagnostic and Statistical Manual-IV 
(DSM-IV) (American Psychiatric Association, 1994) criteria. 
 
Indicators of suicide vulnerability 
Indicators of suicide vulnerability were provided by two measures at baseline and 12-
month follow-up. Suicidal ideation was measured using item 9 of the BDI-II (suicidal 
thoughts or wishes), a single item that is scored on a 4-point scale from 0-3, which has 
been confirmed as a valid method for assessing suicidal ideation (Desseilles et al., 2012). 
Hopelessness was assessed using the BHS, a 20-item measure of feelings of hopelessness 
during the previous week.  
 
Review of therapeutic factors 
During sessions 1, 5 and 10 participants and therapists completed the Agnew-Davies 
Relationship Measure (Agnew et al., 1998), a self-report questionnaire measuring 
perceptions of the client-therapist relationship (therapeutic alliance).  
In view of the differing natures of the treatment types, there may have been 
different opportunities to discuss suicide in each condition. To avoid a potentially misleading 
attribution of differences in suicide vulnerability at 12 months to treatment type, rather than, 
for example, to actual time spent treating suicidality, a review of taped therapy sessions was 
conducted. A random sample of treatment sessions was selected so that where possible an 
audio tape of one session from each participant was played back, with the researcher 
recording the number of times suicide was discussed, and the total amount of time spent 
discussing suicide, per session.  
 
Statistical analysis 
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Data analysis was completed using PASW Statistics 18 for Windows (Release 18.0.0, 
SPSS Inc, Chicago, Ill, USA). All participants who completed 12-month follow-up were 
included, regardless of whether they had completed all 10 sessions of treatment. 
Variables were generated to look at clinically significant reductions in both suicidal 
ideation and hopelessness. A clinically significant reduction in suicidal ideation was 
conceptualised as at least a one-point decrease on item 9 of the BDI-II; for example, a 
change from "I would kill myself if I had the chance" to "I would like to kill myself." A 
clinically significant improvement on the BHS was conceptualised as an improvement of at 
least one category, that is from “severe” (total score 15-20) to “moderate” (total score 9-
14); from “moderate” to “mild” (total score 4-8); or from “mild” to “minimal” (total score 0-
3). A chi-square analysis was used to explore these changes. 
Linear regressions predicted suicidal ideation and hopelessness respectively at 12 
months. These models controlled for the baseline value of each outcome, demographics 
(age, gender, marital status, employment status and urban/rural location), and number of 
sessions attended. To compare treatment types, five orthogonal contrasts were generated: 
(a) PCT versus CBT; (b) single-focused versus integrated treatments; (c) computer-delivered 
versus therapist-delivered integrated treatment; (d) depression-focused versus alcohol-
focused therapy; and (e) brief versus 10-session treatment. This regression was also 
repeated for depressive symptoms and alcohol use. Since participants were initially selected 
for higher suicide vulnerability, we acknowledged the possibility of regression to the mean; 
therefore regressions were repeated including all participants with complete data, not just 
those for whom suicide vulnerability was elevated.  
Due to the relatively low retention rate at 12-month follow-up, two sets of analyses 
were undertaken. The initial, primary analysis was conducted after using multiple imputation 
to account for missing values. A fully conditional speculation model was used, with 10 
iterations, to replace missing data for each of our four outcomes at 12 months. Each of the 
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four outcomes was imputed using baseline demographics, and baseline values of each 
outcome. To maximise the accuracy of the imputation, values of each outcome from 
previous DAISI and SHADE follow-up time points (3 and 6 months) were also used as 
predictors. Following this, a secondary “efficiency” analysis was conducted, including only 
participants with complete data, to explore any potential effects of data imputation. 
Correlations between change in suicidal ideation, hopelessness, depression and 
alcohol use were conducted. 
To partially control for the number of statistical tests in this analysis, a Bonferroni 
correction was used for all multivariate analyses. A family-wise error rate was chosen, 
controlling for the four outcomes variables; therefore a significance level of .0125 was set.  
 
Ethical considerations 
Ethics approval for the two original clinical trials was obtained from the human 
research ethics committees (HREC) of Hunter New England Health, the University of 
Newcastle, Queensland University of Technology, Northern Sydney, Central Coast Health 
and Mid West Area Health Service. For the current analysis, approval was obtained from the 
primary HREC at the University of Newcastle to integrate the DAISI and SHADE data sets 
and explore suicide vulnerability as an outcome. All participants provided written informed 
consent to take part in treatment and to complete 12-month follow-up.  
 
Results 
 The overall results for the original DAISI and SHADE studies have been reported in 
full elsewhere (Baker et al., 2010; Kay-Lambkin et al., 2011). 
 
Baseline characteristics 
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At baseline, 195 (68.7%) DAISI and 108 (39.4%) SHADE participants met our 
criteria (303 total). Data were collected from 181 (139 DAISI, 42 SHADE) of these 
participants at 12-month follow-up, resulting in a retention rate of 59.7%. However, after 
using multiple imputation, full data was available for all participants. There were no 
differences between baseline (or follow-up) scores for suicidal ideation, hopelessness, 
depression or alcohol use between participants whose follow-up data was imputed, 
compared with those with complete data. The mean age of the sample was 43.4 years; 163 
(53.8%) were male, 95 (31.4%) were married and 142 (46.9%) were employed at baseline. 
At baseline, 184 participants (60.7%) met 12-month DSM-IV criteria for Major 
Depressive Disorder, with 97 (32.0%) meeting sub-threshold criteria. Alcohol dependence 
was diagnosed in 255 people (84.2%), while 19 (6.3%) met criteria for alcohol abuse. The 
mean suicidal ideation score was 1.00 (±0.76), while the mean hopelessness score was 
12.27 (±4.50). There was no difference in these scores across treatment conditions. Both 
higher suicidal ideation (r = .36, p < .001) and higher hopelessness (r = .26, p < .001) 
were correlated with higher depressive symptoms at baseline. 
 
Insert Table 1 near here 
12-month follow-up 
Table 1 shows the means and standard deviations for the four outcome measures at 
baseline and 12 months; the regression analysis is shown in Table 2. 
 
Depressive symptoms 
Depressive symptoms at 12 months were significantly lower than baseline, F (1,302) 
= 156.32, p < .001. When client characteristics were controlled for, there were no 
differences observed between treatment conditions (Table 2).  
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Alcohol use 
Alcohol use decreased significantly by 12 months, F (1,302) = 44.46, p < .001. The 
regression to predict alcohol use at 12 months was significant (Table 2). When client 
characteristics were controlled for there were no differences observed between treatment 
conditions.  
 
Insert Figure 2 near here 
 
Suicide vulnerability 
At baseline, 236 participants reported some level of suicidal ideation. By 12 months, 
147 of these people (62.3%) had decreased by at least one point on the BDI-II item 9. 
Follow-up suicidal ideation is depicted in Figure 2a, with reference to categories reported at 
baseline. Between baseline and follow-up, there was no significant decrease in the severity 
of suicidal ideation overall (p = .299). As shown in Figure 3a, on a univariate level, the 
severity of suicidal ideation was least likely to decrease in the PCT and computer-delivered 
CBT conditions. However, after controlling for baseline scores and client characteristics, no 
differences in suicidal ideation were observed between conditions (Table 2). 
 
Insert Figure 3 and Table 2 near here 
 
Eighty-two of the 200 participants reporting baseline hopelessness (49.0%) 
decreased their score on the BHS by at least one category, as shown in Figure 2b. At 12 
months, the severity of hopelessness had decreased significantly across the sample, F 
(1,302) = 33.76, p < .001. However, as shown in Figure 3b, this decrease did not occur 
consistently across conditions, with minimal change observed in the PCT and computer-
integrated CBT conditions. This was reflected in the regression model shown in Table 2. This 
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model found that two orthogonal contrasts significantly predicted hopelessness at follow-up. 
The PCT condition displayed less improvement than participants who received CBT, while 
the integrated CBT conditions improved less than the single-focused conditions. A trend was 
also observed for computer-delivered treatment leading to smaller improvements than 
therapist-delivered treatment, however this effect did not meet our Bonferroni criterion for 
significance. 
 
 Efficiency analysis 
There was a significant difference in 12-month retention rates across treatment 
conditions, with the lowest retention in the computer-integrated CBT and PCT conditions 
(brief intervention 63.6%, depression-focused CBT 73.3%, alcohol-focused CBT 66.0%, 
therapist-integrated CBT 61.5%, computer-integrated CBT 44.4%, PCT 37.5%), χ²(5) = 
15.86, p = .007. Participants who did not complete follow-up reported significantly higher 
alcohol use at baseline (11.72±9.88) compared to those who were retained (8.99±5.94), F 
(1,302) = 8.97, p = .003.  
When analyses were repeated using only participants with complete, non-imputed 
data, several differences in results were observed. Firstly, the overall change in severity of 
suicidal ideation was significant (1.01±0.76 vs. 0.44±0.58, F (1,179) = 71.75, p < .001). 
Secondly, reductions in hopelessness were significantly greater in therapist- versus 
computer-delivered CBT (β = 0.24, t = 3.13, p = .002). Lastly, reductions in alcohol use 
were significantly greater in the alcohol-focused versus depression-focused condition (β = -
0.27, t = -3.41, p = .001). 
 
Inclusive analysis 
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After completing the analysis of all participants who completed 12-month follow-up 
(n = 378), rather than just those with elevated suicide vulnerability at baseline, we observed 
the same pattern of significance in our results for suicidal ideation, depression and alcohol 
use (i.e. there were no significant differential treatment effects). The same pattern of results 
was also observed for hopelessness, with one additional finding. Computer-delivered CBT 
led to significantly smaller reductions in hopelessness at 12 months than therapist-delivered 
CBT (β = 0.18, t = 2.83, p = .006).  
 
Change in clinical symptoms 
Change in suicidal ideation did not correlate significantly with change in hopelessness 
(r  = 0.16, p = .095); trends with change in depression (r = 0.45, p = 0.23) and alcohol use 
(r = -0.16, p = .021) did not meet our Bonferroni criterion for significance. Hopelessness 
changed significantly in accordance with depression (r = .32, p = .002), but not with alcohol 
use (r = -0.09, p = .249).  
 
Therapeutic factors  
Overall 91 therapy tapes were reviewed for mentions of suicidality. This included 24 
depression-focused, 25 alcohol-focused, 27 therapist-integrated, nine computer-integrated, 
and six PCT sessions. In total, suicidality was discussed in 27 sessions (30%); there were no 
differences between conditions in either the number of times per session suicide was raised 
(1.4±0.80, range 1–4), or in the amount of time spent discussing suicidality per session 
(2m34s±3m42s, range 0m4s–12m49s).  
There was no difference in the number of sessions attended between 10-session 
treatment conditions, and neither participants nor therapists reported significant differences 
in therapeutic alliance between treatment conditions. 
19 
 
 
Discussion 
The present analysis provides mixed evidence as to the effectiveness of CBT with MI 
in reducing suicide vulnerability in clinical populations. It is important to note that the aim of 
DAISI and SHADE was not to reduce suicide vulnerability, and the observed results pertain 
only to non-specific treatment for suicidality. After ten sessions of CBT and MI, statistically 
significant reductions were observed in the severity of hopelessness; this is consistent with 
previous research conducted in smaller samples (Rush et al., 1982), although CBT in the 
current study did not focus specifically on suicide vulnerability. The clinical significance of 
this finding is less clear; only half of participants with baseline hopelessness reduced their 
symptoms by at least one point by 12 months, indicating room to improve on this outcome. 
The findings for suicidal ideation are also open to mixed interpretation. Although 
about two-thirds of participants with baseline suicidal ideation reduced their symptoms by at 
least one point by follow-up, there was no overall significant decrease in the severity of 
suicidal ideation across the sample. Considering that the treatment provided in DAISI and 
SHADE was not aiming to reduce suicide vulnerability, these results are perhaps not 
unexpected, however they do have important implications. CBT targeting primary diagnoses 
is a common treatment approach for depression and alcohol misuse, and suicide 
vulnerability may often not be targeted directly. Our results put into question the 
appropriateness of this, with the remission rates observed indicating room to improve on the 
outcomes for both hopelessness and suicidal ideation, and it is possible that treatments 
either focusing on suicide vulnerability specifically, or incorporating suicidality modules into 
the treatment agenda, would lead to greater reductions. Further research to explore this 
potential would be valuable. 
PCT was associated with a significantly smaller reduction in hopelessness than CBT 
treatments, suggesting that the structure and format of CBT with MI may be better suited to 
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treat vulnerability for suicidal thinking, as indicated in previous research (Rush et al., 1982; 
Raj et al., 2001). A similar finding was observed for integrated CBT, which had less effect on 
hopelessness than either single-focused treatment. 
There are several potential explanations for our findings, which suggest a lower 
capacity for PCT and integrated CBT to reduce hopelessness (in their current formats). The 
content of PCT was determined by participants, hence issues were not discussed during 
therapy unless the participant chose to do so. While exceptions were made in the presence 
of suicidal ideation, this allowance was not in place for hopelessness. The current analysis 
also found that single-focused treatments were more effective than integrated therapy for 
reductions in hopelessness; although it needs to be acknowledged that all treatment 
conditions began with a single common session addressing both depression and alcohol 
misuse. While we are not aware of previous research exploring integrated treatments for 
hopelessness in a comorbid population, this finding was contrary to our hypothesis that a 
treatment addressing both problems may be needed in that context (Lecrubier et al., 2001). 
It may be that simpler, single-focused interventions have a better impact on hopelessness 
as they convey a less complex message. With treatment focusing on only one disorder, the 
content of each session and the ultimate goal of therapy are clearer, and may increase client 
confidence that they can change their behaviour, incidentally reducing hopelessness.  
Both the efficiency analysis and the inclusive analysis indicated smaller 
improvements for computer-delivered, compared with therapist-delivered, integrated CBT. 
This effect was not observed in the main regression, which may have been due to power 
issues considering that computer-integrated CBT had the smallest allocation of participants. 
Regardless, the inconsistency of findings between these two analyses should be interpreted 
with caution. Therapist delivery and engagement within CBT may be a key component of 
hopelessness treatment. Indeed, the significance of the therapists’ role in treating 
hopelessness during CBT for suicidal ideation has been highlighted (Collins & Cutcliffe, 
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2003). However, there were no differences in therapeutic alliance across therapist- and 
computer-delivered conditions. These findings may also reflect the format of present 
analyses, which did not allow equal opportunity to address hopelessness in each treatment 
condition. The computer-delivered condition had little input from the therapist beyond the 
brief check-in at the completion of each session, with no measure of hopelessness included 
in the check-in, nor direction to apply CBT strategies to thoughts related to hopelessness. 
Including a protocol for dealing with hopelessness in all treatments, as was done for suicidal 
ideation, may enhance the capacity to monitor and act on these symptoms equally across 
conditions.  
While several important effects were observed for hopelessness, the findings for 
suicidal ideation are less clear. Despite the lack of a statistically significant decrease in the 
severity of suicidal ideation, there was evidence for clinically meaningful changes in this 
outcome. These findings align with previous evidence that, despite a strong association, 
depression and suicidal ideation are independent conditions (Handley et al., 2012), 
supporting the need for “suicide specific” components when targeting suicidal ideation 
within depression. It is possible that, as suicidal ideation is often considered a long-term 
condition, statistically significant changes may have been observed had a longer follow-up 
time been employed. A statistically significant effect was observed in the efficiency analysis, 
suggesting that the effects may have been diluted by imputing such a large proportion of 
the outcome data.  
In the present analysis, there were no significant differences in treatment outcomes 
for either hopelessness or suicidal ideation between brief and 10-session interventions. This 
mirrors the original DAISI findings for depressive symptoms (Baker et al., 2010). A 
systematic review of CBT for suicide vulnerability reported that no previous studies have 
focused on the effects of single-session treatments (Tarrier et al., 2008), thus we are unable 
to compare our findings to previous explorations of this outcome. While this finding does 
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suggest equivalence between brief and longer-term therapies, this must be viewed in light 
of the present analysis’ modest reductions in suicide vulnerability. As suicidality is often a 
long-term, recurring condition in clinical samples (Williams et al., 2006), regular monitoring 
and contact with services is likely to be advisable.  
The absence of correlation between change in suicidal ideation and hopelessness 
supports previous findings (Beck et al., 1985) and suggests that these factors may need to 
be addressed separately to alleviate suicide vulnerability. The presence of hopelessness has 
been linked with the development of suicidal ideation and attempts (Kuo et al., 2004), and 
residual hopelessness is associated with attempted and completed suicide even after 
depressive symptoms have subsided (Szanto et al., 2002). Treatments focusing specifically 
on increasing hope and sense of purpose have been successful in other client conditions, 
such as in patients with cancer (McClement & Chochinov, 2008; Lethborg et al., 2008; 
Breitbart et al., 2010); adapting these approaches towards co-occurring depression and 
alcohol misuse may reduce hopelessness and suicide vulnerability in this condition. 
Change in hopelessness correlated positively with change in depressive symptoms, 
indicating that the treatment of depression is likely to be important, although not sufficient, 
in the management of suicide vulnerability (consistent with existing recommendations; 
Rihmer, 2001). Importantly, however, it has been proposed that hopelessness may have 
multiple components; a state component that varies alongside depression severity, and a 
trait component that occurs independently (Young et al., 1996). Hopelessness has been 
identified as a key component of demoralisation, which may occur independently of 
depression yet still present significant vulnerability for suicide (Clarke & Kissane, 2002). This 
implies that treating depression alone is unlikely to alleviate suicide vulnerability, and the 
additional components of treatment that effectively targeted hopelessness may not have 
been present in PCT or the integrated treatments.  
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Neither changes in suicidal ideation or hopelessness correlated with change in 
alcohol use. Considering the mean alcohol scores were above recommended drinking levels 
both at baseline and follow-up, this may indicate a threshold effect, where suicide 
vulnerability is higher in individuals drinking above a certain level, rather than a linear effect. 
While we cannot conclude that reductions in alcohol use are important for the resolution of 
suicide vulnerability, our results concur with previous research in that they do not suggest 
that this relationship is directly causative for this outcome (Caces & Harford, 1998).  
Limitations to the study include the use of a single-item measure of suicidal ideation, 
enabling us to explore only changes in the severity of thoughts of suicide, rather than the 
frequency of thoughts, or actual suicidal behaviours. The limited variation in this single-item 
measure may in part account for the lack of significant decrease in the overall severity of 
suicidal ideation in the present analysis. As all CBT conditions also contained a motivational 
interviewing component, we cannot ascertain whether our findings are due to CBT itself, or 
to the combination of these strategies. The aggregation of two independent data sets for 
the present analysis is a source of both strengths and limitations. Although we imposed 
inclusion criteria on the present analysis to make participant groups as similar as possible, as 
well as controlling for additional potential differences between studies, it is possible that the 
DAISI and SHADE studies were subject to other sources of heterogeneity that were not 
anticipated and hence not controlled for. Conversely, combining the data sets allowed for a 
sufficient sample size to conduct the multivariate analyses, which would have been far more 
restricted if conducted in either data set independently. It also allowed analyses to be 
conducted over a range of different treatment conditions, greatly increasing the range of 
comparisons we were able to make. While the results presented may be regarded as only 
preliminary evidence, directions for future research were indicated. 
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Figure 1. Subset of DAISI and SHADE participants included in the current analysis 
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Table 1. Mean (standard deviation) of the four outcome measures at baseline and 12-months 
  Brief 
intervention 
Depression-
focused 
Alcohol-
focused 
Therapist 
integrated 
Computer 
integrated 
PCT Overall 
Depression 
Baseline 30.09 (7.26) 31.89 (8.88) 31.04 (8.19) 31.06 (7.43) 31.73 (7.43) 31.79 (8.27) 31.21 (7.83) 
12-months 22.18 (13.54) 16.48 (12.55) 17.68 (13.21) 20.29 (13.56) 20.45 (13.92) 25.61 (12.02) 20.26 (13.49) 
Alcohol use 
Baseline 8.56 (6.36) 9.83 (7.61) 9.78 (6.98) 9.62 (6.83) 14.96 (12.83) 9.01 (5.20) 10.10 (7.88) 
12-months 6.03 (5.76) 8.01 (6.57) 5.57 (5.59) 6.00 (6.80) 6.02 (9.67) 6.28 (6.90) 6.23 (6.90) 
Suicidal ideation 
Baseline 0.98 (0.66) 1.09 (0.79) 0.96 (0.73) 0.99 (0.79) 0.95 (0.71) 1.05 (0.84) 1.00 (0.76) 
12-months 0.90 (0.96) 0.86 (0.91) 0.86 (1.05) 0.82 (0.95) 1.04 (1.02) 1.32 (1.03) 0.94 (1.00) 
Hopelessness 
Baseline 12.52 (4.61) 12.93 (4.42) 12.68 (4.73) 11.97 (4.48) 11.89 (4.58) 11.74 (4.27) 12.27 (4.50) 
12-months 9.00 (6.72) 6.64 (6.00) 5.43 (6.26) 10.00 (6.73) 13.56 (6.19) 13.95 (5.32) 9.53 (6.96) 
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Figure 2. Score categories for (a) suicidal ideation, and (b) hopelessness at 12-month follow-up. For suicidal ideation, 0 = I do not have 
thoughts of killing myself; 1 = I have thoughts of killing myself, but would not carry them out; 2 = I would like to kill myself; 3 = I would kill 
myself if I had the chance. 
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Table 2. Linear regressions predicting 12-month suicidal ideation risk and 12-month hopelessness, after controlling for baseline scores, 
number of sessions attended and client demographics 
Orthogonal contrasts 
DepressionΩ Alcohol useπ Suicidal ideation† Hopelessness◊ 
β* t p β* t p β* t p β* t p 
Brief (vs. 10 session) CBT 0.11 1.38 .174 -0.10 -1.19 .239 0.02 0.21 .835 0.04 0.50 .617 
PCT (vs. CBT) 0.15 1.97 .053 -0.02 -0.29 .777 0.14 1.89 .062 0.24 3.60 .001 
Integrated (vs. single-focused) 
treatment 
0.10 0.99 .332 -0.06 -0.74 .465 0.16 0.18 .861 0.34 4.71 <.001 
Computer-delivered (vs. 
therapist-delivered) CBT 
0.01 0.21 .831 0.01 0.07 .947 0.06 0.79 .429 0.16 2.06 .046 
Alcohol (vs. depression) 
treatment 
0.03 0.29 .777 -0.10 -1.72 .086 0.00 0.05 .962 -0.05 -0.64 .525 
* Standardised regression coefficient 
Ω F (12,302) = 2.27, p = .050, R2 = .09 
π F (12,302) = 3.48, p = .011, R2 = .13 
† F (12,302) = 1.32, p = .266, R2 = .05 
◊ F (12,302) = 6.35, p <.001, R2 = .21 
  
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Change from baseline to 12 months in a) suicidal ideation (BDI-II item 9) and; b) hopelessness (BHS total score) 
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